Immunological Evaluation of a Novel Multi-Antigenic Dna Vaccine Encoding Sag1, Sag3, Mic4, Gra5, Gra7, Ama1and Bag1 Against Toxoplasma Gondii in Balb/C Mice Publisher Pubmed



Alijani M^{1, 2} ; Saffar B³ ; Yosefi Darani H⁴ ; Mahzounieh M⁵ ; Fasihiramandi M⁶ ; Shakshiniaei M³ ; Soltani S⁷ ; Ghaemi A⁸ ; Shirian S^{9, 10} Show Affiliations
Source: Experimental Parasitology Published:2023

Abstract

Many recent studies have been conducted to find new DNA vaccines based on Toxoplasma gondii antigens. DNA vaccines encoding complex of different antigens showed better immune responses compared to single antigen vaccine. In this study, we constructed a DNA vaccine encoding SAG1, SAG3, MIC4, GRA5, GRA7, AMA1 and BAG1 against T. gondii, and evaluated the immune response it induced in BALB/c mice. For this purposes, thirty BALB/c mice were randomly divided into three groups containing tenmice each. There were two negative control groups (PBSand pVAX1 vector) and one vaccination group (pVAX1-MAF, Multantigenic Fragment). On days 0, 14 and 28, the mice were immunized intramuscularly, and 5 weeks later they were challenged with T. gondii RH strain. The immune responses were evaluated using lymphocyte proliferation assay, T-cell subsets detection, and measurement of antibody and cytokine levels. The results showed that mice immunized with pVAX1-MAF developed high levels of IL-2, IL-12, IgG and IFN- γ as well as CD3+CD4+ T cells. In addition, the survival time of mice immunized by pVAX1-MAF was longer than that control mice. In conclusion, our results show that the multiple DNA vaccine encodingSAG1, SAG3, mic4, GRA5, GRA7, AMA and BAG1effectively enhanced humoral and cellular immune responses, and prolonged the survival time. Together this would suggest that further investigation may result in a promising candidate vaccine to treat toxoplasmosis. © 2022